Detalles de la búsqueda
1.
Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
Oncologist;
26(9): e1633-e1643, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101298
2.
Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
Future Oncol;
17(18): 2339-2350, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709776
3.
Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancer.
Future Oncol;
17(17): 2169-2182, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631973
4.
Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study.
Future Oncol;
16(36): 3045-3060, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32885666
5.
Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted Therapies.
J Thorac Oncol;
18(1): 67-78, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36184067
6.
Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.
Target Oncol;
17(1): 25-33, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964940
7.
Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.
Clin Cancer Res;
28(4): 738-747, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789480
8.
Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy.
Adv Ther;
38(5): 2644-2661, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33866526
9.
Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis.
J Manag Care Spec Pharm;
27(9): 1171-1181, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165322
10.
A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.
Psychosomatics;
50(1): 78-86, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19213976
11.
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
CNS Drugs;
22(11): 963-73, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18840035
12.
History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.
Prim Care Companion J Clin Psychiatry;
10(5): 368-75, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19158975
13.
Reply to the Letter to the Editor From Zhao et al.
J Thorac Oncol;
18(3): e27-e28, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842816
14.
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.
J Am Acad Child Adolesc Psychiatry;
45(4): 422-30, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16601647
15.
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
J Am Acad Child Adolesc Psychiatry;
45(6): 709-719, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16721321
16.
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.
J Child Adolesc Psychopharmacol;
16(1-2): 77-90, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16553530
17.
History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia.
Prog Neuropsychopharmacol Biol Psychiatry;
33(6): 996-1002, 2009 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-19433129
18.
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
World J Biol Psychiatry;
10(4 Pt 2): 435-41, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19382010
19.
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Neuropsychopharmacology;
33(13): 3201-12, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18418363
20.
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
J Clin Psychiatry;
69(3): 400-5, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18348595